Bioxcel therapeutics reports qtrly loss per share $0.57

Bioxcel therapeutics reports third quarter 2019 financial results and provides business update.bioxcel therapeutics reports third quarter 2019 financial results and provides business update.qtrly loss per share $0.57.as of september 30, cash & cash equivalents totaled approximately $40.3 million.q3 earnings per share view $-0.65 -- refinitiv ibes data.
BTAI Ratings Summary
BTAI Quant Ranking